Mer­ck­'s melanoma drug shows ear­ly promise for re­sis­tant can­cers in PhI tri­al

Ear­ly news on a Mer­ck drug can­di­date has re­searchers hope­ful that the in­ves­ti­ga­tion­al ther­a­py could be used to fight drug re­sis­tant can­cers. The da­ta is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER